New determinants of prognosis in bacterial infections in cirrhosis

Figure 1 Proposed algorithm for the empirical treatment of infections in cirrhosis. ¹Risk factors for multiresistant bacteria in Health care associated infections are long-term norphloxacin prophylaxis or previous infection by multiresistant (MR) bacteria within 6 mo; ²Piperaziline/tazobactam in areas of low MR bacteria but high Enterococcus faecalis prevalence. Meropenem and glycopeptides in areas with high prevalence of extended-spectrum β-lactamase-producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus. SBP: Spontaneous bacterial peritonitis; SBE: Spontaneous bacterial empyema; SB: Spontaneous bacteremia; PPZ/TZB: Piperaziline/tazobactam.